FDA Approves Ebanga (ansuvimab-zykl) for the Treatment of Zaire Ebolavirus Infection December 21, 2020 — The U.S. Food and Drug Administration approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children….